NRX PHARMACEUTICALS INC's ticker is and the CUSIP is 629444900. A total of 3 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,512 | -46.2% | 21,200 | 0.0% | 0.00% | – |
Q2 2023 | $10,250 | -47.1% | 21,200 | -27.9% | 0.00% | – |
Q1 2023 | $19,378 | -83.3% | 29,400 | -71.9% | 0.00% | – |
Q4 2022 | $116,217 | +52.9% | 104,700 | +1.5% | 0.00% | – |
Q3 2022 | $76,000 | +20.6% | 103,200 | -1.2% | 0.00% | – |
Q2 2022 | $63,000 | -78.9% | 104,500 | -14.3% | 0.00% | – |
Q1 2022 | $299,000 | -50.7% | 121,900 | -3.8% | 0.00% | – |
Q4 2021 | $606,000 | +12.8% | 126,700 | +118.8% | 0.00% | -100.0% |
Q3 2021 | $537,000 | – | 57,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 104,500 | $63,000 | 0.00% |
SIMPLEX TRADING, LLC | 4,200 | $2,000 | 0.00% |